Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL673922 | 0.97 | CA1 (0.35) | CA1CA2EPHX1ACHE | |
| SCHEMBL672096 | 0.91 | — | — | |
| SCHEMBL673840 | 0.85 | CA1 (0.33) | CA1CA2EPHX1ACHE | |
| SCHEMBL4453883 | 0.84 | — | — | |
| Water SCHEMBL7648266 | 0.83 | ACHE (0.32) | CA1CA2EPHX1ACHE | |
| SCHEMBL3066085 | 0.80 | CA1 (0.37) | CA1CA2EPHX1ACHECA12 | |
| SCHEMBL24862596 | 0.79 | EPHX1 (0.36) | CA1CA2EPHX1ACHE | |
| SCHEMBL3364907 | 0.78 | CA1 (0.36) | CA1CA2EPHX1ACHECA12 | |
| SCHEMBL13763439 | 0.78 | CA1 (0.36) | CA1CA2EPHX1ACHECA12 | |
| SCHEMBL22321673 | 0.78 | CA1 (0.36) | CA1CA2EPHX1ACHECA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114181250-A | Alkenyl phosphine compound and preparation method thereof | 中国石油化工股份有限公司 | 2022-03-15 | — | — | CN | claimed |
| US-10273577-B2 | Low vapor pressure aerosol-assisted CVD | APPLIED MATERIALS, INC. (US) | 2019-04-30 | — | — | US | claimed |
| US-10163629-B2 | Low vapor pressure aerosol-assisted CVD | APPLIED MATERIALS, INC. (US) | 2018-12-25 | — | — | US | claimed |
| US-20170140920-A1 | LOW VAPOR PRESSURE AEROSOL-ASSISTED CVD | APPLIED MATERIALS, INC. | 2017-05-18 | — | — | US | claimed |
| EP-0996670-B1 | PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS | METABOLIX INC (US) | 2006-05-31 | — | — | EP | claimed |
| US-20040039092-A1 | PHA compositions and methods for their use in the production of PHA films | METABOLIX, INC. | 2004-02-26 | — | — | US | claimed |
| US-6620869-B2 | Polyhydroxyalkanoate (PHA); pellets with high molecular weight PHA; forms films with good elongational and tensile properties | METABOLIX, INC. | 2003-09-16 | — | — | US | claimed |
| US-20020061944-A1 | PHA compositions and methods for their use in the production of PHA films | MONSANTO COMPANY | 2002-05-23 | — | — | US | claimed |
| EP-0996670-A1 | PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS | MONSANTO COMPANY (US) | 2000-05-03 | — | — | EP | claimed |
| WO-1999005207-A1 | PHA COMPOSITIONS AND METHODS FOR THEIR USE IN THE PRODUCTION OF PHA FILMS | MONSANTO COMPANY (US) | 1999-02-04 | — | — | WO | claimed |
| US-5344966-A | Hydrogenation of phenylphosphonic acid | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-09-06 | — | — | US | claimed |
| US-4213942-A | Process for the concentration of mineral by flotation process | Groupe Minier Sullivan Ltee/Sullivan Mining Group Ltd. (CA) | 1980-07-22 | — | — | US | claimed |
| US-12605875-B2 | Method for producing polymeric molded product comprising pretreatment by heating | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-20250346898-A1 | Linkage Modified Oligomeric Compounds and Uses Thereof | IONIS PHARMACEUTICALS, INC. (US) | 2025-11-13 | — | — | US | disclosed |
| EP-4532724-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | Ionis Pharmaceuticals, Inc. (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023235817-A1 | LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF | IONIS PHARMACEUTICALS, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-4148983-A | TERTIARY CATALYST SYSTEM INCLUDING AN ORGANOMETALLIC COMPOUND, A CHROMIUM COMPOUND AND AN ORGANIC PHOSPHITE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1979-04-10 | — | — | US | disclosed |
| US-4138553-A | 3-Methylene cephalosporanic acid derivatives and process for preparation thereof | TEIJIN LIMITED (JP) | 1979-02-06 | — | — | US | disclosed |
| US-4070392-A | ACID CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1978-01-24 | — | — | US | disclosed |
| US-3972890-A | ACID CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605875-B2 | Method for producing polymeric molded product comprising pretreatment by heating | HPD, HAO2, PGD | CA1 1353/4885CA2 1023/4885EPHX1 1301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.